Cargando…

COVID-19 and the pulmonary vasculature

Detalles Bibliográficos
Autores principales:	Provencher, Steeve, Potus, François, Bonnet, Sébastien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288817/ https://www.ncbi.nlm.nih.gov/pubmed/32577218 http://dx.doi.org/10.1177/2045894020933088

Ejemplares similares

Signal transduction in the development of pulmonary arterial hypertension
por: Malenfant, Simon, et al.
Publicado: (2013)

Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms
por: Malenfant, Simon, et al.
Publicado: (2021)

Pulmonary vasculature in COVID-19: mechanism to monitoring!
por: Magoon, Rohan
Publicado: (2021)

Dual ET(A)/ET(B) blockade with macitentan improves both vascular remodeling and angiogenesis in pulmonary arterial hypertension
por: Nadeau, Valerie, et al.
Publicado: (2017)

Venous thromboembolism in COVID-19 compared to non-COVID-19 cohorts: A systematic review with meta-analysis
por: Mai, Vicky, et al.
Publicado: (2021)

Combination therapy in pulmonary arterial hypertension: recent accomplishments and future challenges
por: Lajoie, Annie-Christine, et al.
Publicado: (2017)

HDAC6: A Novel Histone Deacetylase Implicated in Pulmonary Arterial Hypertension
por: Boucherat, Olivier, et al.
Publicado: (2017)

Recovery of exercise capacity after COVID-19 pneumonia: Key role of right ventricular-pulmonary circulation unit: The role of pulmonary vasculature in exercise after COVID-19 pneumonia
por: Rinaldo, R.F., et al.
Publicado: (2022)

PARP1-PKM2 Axis Mediates Right Ventricular Failure Associated With Pulmonary Arterial Hypertension
por: Shimauchi, Tsukasa, et al.
Publicado: (2022)

Pim-1: A new biomarker in pulmonary arterial hypertension
por: Renard, Sébastien, et al.
Publicado: (2013)

DNA Damage and Pulmonary Hypertension
por: Ranchoux, Benoît, et al.
Publicado: (2016)

The cancer theory of pulmonary arterial hypertension
por: Boucherat, Olivier, et al.
Publicado: (2017)

Alternatives to the Six-Minute Walk Test in Pulmonary Arterial Hypertension
por: Mainguy, Vincent, et al.
Publicado: (2014)

Interpreting risk reduction in clinical trials for pulmonary arterial hypertension
por: Lajoie, Annie C., et al.
Publicado: (2018)

Reply: Posterior lenticonus with persistent fetal vasculature
por: Khokhar, Sudarshan, et al.
Publicado: (2019)

Implication of EZH2 in the Pro-Proliferative and Apoptosis-Resistant Phenotype of Pulmonary Artery Smooth Muscle Cells in PAH: A Transcriptomic and Proteomic Approach
por: Habbout, Karima, et al.
Publicado: (2021)

Continuous reduction in cerebral oxygenation during endurance exercise in patients with pulmonary arterial hypertension
por: Malenfant, Simon, et al.
Publicado: (2020)

Fetal Gene Reactivation in Pulmonary Arterial Hypertension: GOOD, BAD, or BOTH?
por: Lemay, Sarah-Eve, et al.
Publicado: (2021)

Salmon pink patch sign: Diagnosing persistent fetal vasculature
por: Khokhar, Sudarshan, et al.
Publicado: (2016)

Pulmonary Vasculature: A Target for COVID-19
por: Chen, Lingdan, et al.
Publicado: (2021)

Identity crisis in pulmonary arterial hypertension
por: Ruffenach, G., et al.
Publicado: (2017)

Macrophage–NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension
por: Al-Qazazi, Ruaa, et al.
Publicado: (2022)

Tumor microenvironment‐dependent epigenetic imprinting in the vasculature predicts colon cancer outcome
por: Naschberger, Elisabeth, et al.
Publicado: (2023)

Pulmonary hypertension-targeted therapies in heart failure: A systematic review and meta-analysis
por: Guay, Charles-Antoine, et al.
Publicado: (2018)

2251: An estrogen receptor α (ERα)-BMPR2-apelin axis mediates 17β-estradiol’s protective effects on right ventricular function in experimental pulmonary hypertension (PH)
por: Lee Frump, Andrea, et al.
Publicado: (2018)

Effect of COVID 19 infection on pulmonary vasculature by HRCT
por: Patted, Suresh V., et al.
Publicado: (2021)

Pulmonary Embolism, Pulmonary Microvascular Thrombosis, or Both in COVID-19?
por: Páramo, José A.
Publicado: (2020)

Decompensated primary hypoparathyroidism in a patient with COVID-19
por: Bonnet, Jean-Baptiste, et al.
Publicado: (2021)

Acute Myocarditis With Ventricular Noncompaction in a COVID-19 Patient
por: Bonnet, Marc, et al.
Publicado: (2020)

The pulmonary circuit dynamics in COVID-19!
por: Magoon, Rohan
Publicado: (2020)

Pulmonary toxicity by oxygen and COVID-19()
por: León-Jiménez, A., et al.
Publicado: (2022)

Assessment of Daily Life Physical Activities in Pulmonary Arterial Hypertension
por: Mainguy, Vincent, et al.
Publicado: (2011)

The pulmonary vasculature in lethal COVID-19 and idiopathic pulmonary fibrosis at single-cell resolution
por: de Rooij, Laura P M H, et al.
Publicado: (2022)

Compromised Cerebrovascular Regulation and Cerebral Oxygenation in Pulmonary Arterial Hypertension
por: Malenfant, Simon, et al.
Publicado: (2017)

Neutrophil-Lymphocyte Ratio as an Independent Predictor of Survival in Pulmonary Arterial Hypertension: An Exploratory Study
por: Jutras-Beaudoin, Naomie, et al.
Publicado: (2021)

Krüppel-like Factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension
por: Courboulin, Audrey, et al.
Publicado: (2011)

Low total cholesterol blood level is correlated with pulmonary severity in COVID-19 critical ill patients
por: Ressaire, Quentin, et al.
Publicado: (2020)

Pulmonary Fibrosis Due to COVID-19 Pneumonia
por: Kayhan, Servet, et al.
Publicado: (2020)

COVID-19-associated invasive pulmonary aspergillosis
por: Rutsaert, Lynn, et al.
Publicado: (2020)

Pulmonary administration of remdesivir in the treatment of COVID-19
por: Rasmussen, Henrik Berg, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7rno4gqp1e8pp92i1j6ngtmku5